<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03144427</url>
  </required_header>
  <id_info>
    <org_study_id>ABuRN-001</org_study_id>
    <secondary_id>W81XWH-16-2-0048 Log#MB150076</secondary_id>
    <nct_id>NCT03144427</nct_id>
  </id_info>
  <brief_title>The Acute Burn Resuscitation Multicenter Prospective Observational Trial</brief_title>
  <acronym>ABRUPT</acronym>
  <official_title>The Acute Burn Resuscitation Multicenter Prospective Observational Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Burn Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Army Medical Research Acquisition Activity</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Davis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>American Burn Association</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, non-interventional, observational study of consecutive burn patients
      admitted to 20 selected burn centers in North America. Primarily, data collection will be
      continuous &quot;real-time&quot; documentation of fluid infusion rates, vital signs and laboratory
      values of patients receiving fluid resuscitation during the first 48 hours following burn
      injury. All aspects of the resuscitation and all investigations performed will be according
      to the participating center's regular protocol, as this is purely an observational and
      non-interventional study. Further data collection on outcomes (organ function, ventilation
      duration, length of stay, and survival) will be collected at 72h, 96 h, and at hospital
      discharge.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective observational study with no intervention. Study sites have been
      selected to include wide cross-representation of resuscitation practices using crystalloids
      alone, crystalloid plus albumin, and among sites that use albumin, variable approaches to the
      timing of albumin initiation.

      Detailed data will be continuously collected in &quot;real time&quot; during fluid resuscitation over
      the 1st 48 hours following a burn injury. Data collection during this phase will be done
      prospectively, hour-by-hour, by the bedside nurse caring for the patient. Primarily this data
      collection will involve recording of resuscitation fluid volumes, urinary output, vital signs
      (heart rate and blood pressure), and use of vasopressors and inotropes. Outcome data (organ
      function, need for mechanical ventilation, hospital length of stay, and survival) will be
      collected at various time points during the subjects' acute care stay.

      At completion of the study we intend to make the following comparisons:

        1. Subjects that received crystalloids only compared to subjects that received crystalloids
           plus albumin.

        2. Subjects that had albumin started &quot;early&quot; (&lt; 8 hours post burn), compared to subjects
           that had albumin started &quot;intermediate&quot; (8-12 hours post burn), compared to subjects
           that had albumin started &quot;late&quot; (&gt;12 hours post burn).

        3. Characteristics of resuscitation prior to the start of albumin (&quot;pre-albumin&quot;) compared
           to characteristics of resuscitation following initiation of albumin (&quot;post albumin&quot;).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 24, 2017</start_date>
  <completion_date type="Anticipated">August 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fluid resuscitation volume</measure>
    <time_frame>24 hours post burn injury</time_frame>
    <description>Total fluid resuscitation volume in mL/kg/% TBSA (total body surface area) burn</description>
  </primary_outcome>
  <primary_outcome>
    <measure>albumin : crystalloid ratio</measure>
    <time_frame>24 hours hours post burn injury</time_frame>
    <description>albumin : crystalloid ratio ( mL albumin : mL crystalloid, and, grams albumin : mL crystalloid)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fluid resuscitation volume</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>Total fluid resuscitation volume in mL/kg/% TBSA burn</description>
  </primary_outcome>
  <primary_outcome>
    <measure>albumin : crystalloid ratio</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>albumin : crystalloid ratio ( mL albumin : mL crystalloid, and, grams albumin : mL crystalloid)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>I/O Ratio</measure>
    <time_frame>24 hours post burn injury</time_frame>
    <description>Total intake and output ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>I/O Ratio</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>Total intake and output ratio</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doses of vasopressors and inotropes</measure>
    <time_frame>24 hours post burn injury</time_frame>
    <description>Total doses of vasopressors and inotropes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Doses of vasopressors and inotropes</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>Total doses of vasopressors and inotropes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasciotomy</measure>
    <time_frame>during the first 48 hours post burn injury</time_frame>
    <description>Documentation of fasciotomy performed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>abdominal compartment syndrome</measure>
    <time_frame>during the first 48 hours post burn injury</time_frame>
    <description>Occurrence of abdominal compartment syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>completion of resuscitation</measure>
    <time_frame>up to 48 hours post burn injury</time_frame>
    <description>Time to completion of resuscitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AKIN Score (acute kidney injury network)</measure>
    <time_frame>24 hours post burn injury</time_frame>
    <description>Acute Kidney Injury Network stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AKIN Score</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>Acute Kidney Injury Network stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AKIN Score</measure>
    <time_frame>72 hours post burn injury</time_frame>
    <description>Acute Kidney Injury Network stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AKIN Score</measure>
    <time_frame>96 hours post burn injury</time_frame>
    <description>Acute Kidney Injury Network stage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score (sequential organ failure assessment)</measure>
    <time_frame>24 hours post burn injury</time_frame>
    <description>Sequential Organ Failure Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>48 hours post burn injury</time_frame>
    <description>Sequential Organ Failure Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>72 hours post burn injury</time_frame>
    <description>Sequential Organ Failure Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SOFA score</measure>
    <time_frame>96 hours post burn injury</time_frame>
    <description>Sequential Organ Failure Assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mechanical Ventilation</measure>
    <time_frame>from date of hospital admit until date of hospital discharge, assessed over duration of hospitalization up to 12 months</time_frame>
    <description>Duration of mechanical ventilation and ventilator free days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay</measure>
    <time_frame>from date of hospital admit until date of hospital discharge, assessed over duration of hospitalization up to 12 months</time_frame>
    <description>Length of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>28 days post burn injury or death, whichever occurs first</time_frame>
    <description>In hospital and 28 day survival</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Burns</condition>
  <condition>Shock</condition>
  <arm_group>
    <arm_group_label>Burns</arm_group_label>
    <description>Patients with burns to 20% or more of their BSA (body surface area) require resuscitation with intravenous crystalloid fluids in order to avoid organ failure and death</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients must be ≥ 18 years of age with a TBSA burn of ≥ 20%, and they must have been
        admitted to the burn center ≤ 12 hours following the injury.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age ≥ 18 years

          -  ≥ 20% TBSA burns

          -  Admitted to the burn center ≤ 12 post injury

        Exclusion Criteria:

          -  Significant associated trauma

          -  High voltage (≥ 1000 volts) electrical burns

          -  Surgery anticipated within 48 hours from injury

          -  Fresh frozen plasma (FFP) anticipated to be given at any time ≤ 48 hours from injury

          -  Hypertonic saline (HTS) anticipated to be given at any time ≤ 48 hours from injury

          -  Hydroxyethyl starch (HES) anticipated to be given at any time ≤ 48 hours from injury

          -  High dose Vitamin C infusion is anticipated to be given at any time ≤ 48 hours from
             injury

          -  Death occurs or comfort measures are instituted within ≤ 48 hours from injury
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Greenhalgh, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Davis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katrina Falwell, BSN</last_name>
    <phone>916-453-2134</phone>
    <email>kafalwell@ucdavis.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>MaryBeth Lawless, MS</last_name>
    <phone>916-453-2133</phone>
    <email>mblawless@ucdavis.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of California Davis Medical Center-Regional Burn Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrina Falwell, BSN</last_name>
      <phone>916-453-2134</phone>
      <email>kafalwell@ucdavis.edu</email>
    </contact>
    <contact_backup>
      <last_name>MaryBeth Lawless, MS</last_name>
      <phone>916-453-2133</phone>
      <email>mblawless@ucdavis.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Greenhalgh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Pruitt BA Jr. Protection from excessive resuscitation: &quot;pushing the pendulum back&quot;. J Trauma. 2000 Sep;49(3):567-8.</citation>
    <PMID>11003341</PMID>
  </reference>
  <reference>
    <citation>Zak AL, Harrington DT, Barillo DJ, Lawlor DF, Shirani KZ, Goodwin CW. Acute respiratory failure that complicates the resuscitation of pediatric patients with scald injuries. J Burn Care Rehabil. 1999 Sep-Oct;20(5):391-9.</citation>
    <PMID>10501327</PMID>
  </reference>
  <reference>
    <citation>Hobson KG, Young KM, Ciraulo A, Palmieri TL, Greenhalgh DG. Release of abdominal compartment syndrome improves survival in patients with burn injury. J Trauma. 2002 Dec;53(6):1129-33; discussion 1133-4.</citation>
    <PMID>12478039</PMID>
  </reference>
  <reference>
    <citation>Klein MB, Hayden D, Elson C, Nathens AB, Gamelli RL, Gibran NS, Herndon DN, Arnoldo B, Silver G, Schoenfeld D, Tompkins RG. The association between fluid administration and outcome following major burn: a multicenter study. Ann Surg. 2007 Apr;245(4):622-8.</citation>
    <PMID>17414612</PMID>
  </reference>
  <reference>
    <citation>Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH; PROMMTT Study Group. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013 Feb;148(2):127-36.</citation>
    <PMID>23560283</PMID>
  </reference>
  <reference>
    <citation>Holcomb JB, Fox EE, Wade CE; PROMMTT Study Group. The PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) study. J Trauma Acute Care Surg. 2013 Jul;75(1 Suppl 1):S1-2. doi: 10.1097/TA.0b013e3182983876.</citation>
    <PMID>23778505</PMID>
  </reference>
  <reference>
    <citation>Rahbar MH, Fox EE, del Junco DJ, Cotton BA, Podbielski JM, Matijevic N, Cohen MJ, Schreiber MA, Zhang J, Mirhaji P, Duran SJ, Reynolds RJ, Benjamin-Garner R, Holcomb JB; PROMMTT Investigators. Coordination and management of multicenter clinical studies in trauma: Experience from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study. Resuscitation. 2012 Apr;83(4):459-64. doi: 10.1016/j.resuscitation.2011.09.019. Epub 2011 Oct 12.</citation>
    <PMID>22001613</PMID>
  </reference>
  <reference>
    <citation>Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, del Junco DJ, Brasel KJ, Bulger EM, Callcut RA, Cohen MJ, Cotton BA, Fabian TC, Inaba K, Kerby JD, Muskat P, O'Keeffe T, Rizoli S, Robinson BR, Scalea TM, Schreiber MA, Stein DM, Weinberg JA, Callum JL, Hess JR, Matijevic N, Miller CN, Pittet JF, Hoyt DB, Pearson GD, Leroux B, van Belle G; PROPPR Study Group. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015 Feb 3;313(5):471-82. doi: 10.1001/jama.2015.12.</citation>
    <PMID>25647203</PMID>
  </reference>
  <reference>
    <citation>Cartotto R, Callum J. A review of the use of human albumin in burn patients. J Burn Care Res. 2012 Nov-Dec;33(6):702-17. doi: 10.1097/BCR.0b013e31825b1cf6. Review.</citation>
    <PMID>23143614</PMID>
  </reference>
  <reference>
    <citation>Baxter CR, Shires T. Physiological response to crystalloid resuscitation of severe burns. Ann N Y Acad Sci. 1968 Aug 14;150(3):874-94.</citation>
    <PMID>4973463</PMID>
  </reference>
  <reference>
    <citation>Baxter CR, Marvin J, Curreri PW. Fluid and electrolyte therapy of burn shock. Heart Lung. 1973 Sep-Oct;2(5):707-13.</citation>
    <PMID>4490375</PMID>
  </reference>
  <reference>
    <citation>Pruitt BA Jr. Fluid and electrolyte replacement in the burned patient. Surg Clin North Am. 1978 Dec;58(6):1291-1312.</citation>
    <PMID>734610</PMID>
  </reference>
  <reference>
    <citation>Pruitt BA Jr. The burn patient: II. Later care and complications of thermal injury. Curr Probl Surg. 1979 May;16(5):1-95. Review.</citation>
    <PMID>376227</PMID>
  </reference>
  <reference>
    <citation>Cartotto RC, Innes M, Musgrave MA, Gomez M, Cooper AB. How well does the Parkland formula estimate actual fluid resuscitation volumes? J Burn Care Rehabil. 2002 Jul-Aug;23(4):258-65.</citation>
    <PMID>12142578</PMID>
  </reference>
  <reference>
    <citation>Engrav LH, Colescott PL, Kemalyan N, Heimbach DM, Gibran NS, Solem LD, Dimick AR, Gamelli RL, Lentz CW. A biopsy of the use of the Baxter formula to resuscitate burns or do we do it like Charlie did it? J Burn Care Rehabil. 2000 Mar-Apr;21(2):91-5.</citation>
    <PMID>10752739</PMID>
  </reference>
  <reference>
    <citation>Cancio LC, Chávez S, Alvarado-Ortega M, Barillo DJ, Walker SC, McManus AT, Goodwin CW. Predicting increased fluid requirements during the resuscitation of thermally injured patients. J Trauma. 2004 Feb;56(2):404-13; discussion 413-4.</citation>
    <PMID>14960986</PMID>
  </reference>
  <reference>
    <citation>Cartotto R, Zhou A. Fluid creep: the pendulum hasn't swung back yet! J Burn Care Res. 2010 Jul-Aug;31(4):551-8. doi: 10.1097/BCR.0b013e3181e4d732.</citation>
    <PMID>20616649</PMID>
  </reference>
  <reference>
    <citation>Saffle JI. The phenomenon of &quot;fluid creep&quot; in acute burn resuscitation. J Burn Care Res. 2007 May-Jun;28(3):382-95. Review.</citation>
    <PMID>17438489</PMID>
  </reference>
  <reference>
    <citation>Recinos PR, Hartford CA, Ziffren SE. Fluid resuscitation of burn patients comparing a crystalloid with a colloid containing solution: a prospective study. J Iowa Med Soc. 1975 Oct;65(10):426-32.</citation>
    <PMID>1194720</PMID>
  </reference>
  <reference>
    <citation>Jelenko C 3rd, Williams JB, Wheeler ML, Callaway BD, Fackler VK, Albers CA, Barger AA. Studies in shock and resuscitation, I: use of a hypertonic, albumin-containing, fluid demand regimen (HALFD) in resuscitation. Crit Care Med. 1979 Apr;7(4):157-67.</citation>
    <PMID>446052</PMID>
  </reference>
  <reference>
    <citation>Goodwin CW, Dorethy J, Lam V, Pruitt BA Jr. Randomized trial of efficacy of crystalloid and colloid resuscitation on hemodynamic response and lung water following thermal injury. Ann Surg. 1983 May;197(5):520-31.</citation>
    <PMID>6342554</PMID>
  </reference>
  <reference>
    <citation>Cooper AB, Cohn SM, Zhang HS, Hanna K, Stewart TE, Slutsky AS; ALBUR Investigators. Five percent albumin for adult burn shock resuscitation: lack of effect on daily multiple organ dysfunction score. Transfusion. 2006 Jan;46(1):80-9.</citation>
    <PMID>16398734</PMID>
  </reference>
  <reference>
    <citation>Lawrence A, Faraklas I, Watkins H, Allen A, Cochran A, Morris S, Saffle J. Colloid administration normalizes resuscitation ratio and ameliorates &quot;fluid creep&quot;. J Burn Care Res. 2010 Jan-Feb;31(1):40-7. doi: 10.1097/BCR.0b013e3181cb8c72.</citation>
    <PMID>20061836</PMID>
  </reference>
  <reference>
    <citation>Faraklas I, Lam U, Cochran A, Stoddard G, Saffle J. Colloid normalizes resuscitation ratio in pediatric burns. J Burn Care Res. 2011 Jan-Feb;32(1):91-7. doi: 10.1097/BCR.0b013e318204b379.</citation>
    <PMID>21131844</PMID>
  </reference>
  <reference>
    <citation>25. Mehrkens HH, Ahnefeld FW. Volume and fluid replacement in the early post burn period: an animal experimental study. Burns 1979;5:113-15</citation>
  </reference>
  <reference>
    <citation>Asch MJ, Feldman RJ, Walker HL, Foley FD, Popp RL, Mason AD Jr, Pruitt BA Jr. Systemic and pulmonary hemodynamic changes accompanying thermal injury. Ann Surg. 1973 Aug;178(2):218-21.</citation>
    <PMID>4723430</PMID>
  </reference>
  <reference>
    <citation>Demling RH, Kramer G, Harms B. Role of thermal injury-induced hypoproteinemia on fluid flux and protein permeability in burned and nonburned tissue. Surgery. 1984 Feb;95(2):136-44.</citation>
    <PMID>6695330</PMID>
  </reference>
  <reference>
    <citation>Demling RH, Kramer GC, Gunther R, Nerlich M. Effect of nonprotein colloid on postburn edema formation in soft tissues and lung. Surgery. 1984 May;95(5):593-602.</citation>
    <PMID>6200946</PMID>
  </reference>
  <reference>
    <citation>Onarheim H, Reed RK. Thermal skin injury: effect of fluid therapy on the transcapillary colloid osmotic gradient. J Surg Res. 1991 Mar;50(3):272-8.</citation>
    <PMID>1999916</PMID>
  </reference>
  <reference>
    <citation>Moncrief JA. Effect of various fluid regimens and pharmacologic agents on the circulatory hemodynamics of the immediate postburn period. Ann Surg. 1966 Oct;164(4):723-52.</citation>
    <PMID>5924792</PMID>
  </reference>
  <reference>
    <citation>Park SH, Hemmila MR, Wahl WL. Early albumin use improves mortality in difficult to resuscitate burn patients. J Trauma Acute Care Surg. 2012 Nov;73(5):1294-7. doi: 10.1097/TA.0b013e31827019b1.</citation>
    <PMID>23117385</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2017</study_first_submitted>
  <study_first_submitted_qc>May 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>albumin</keyword>
  <keyword>resuscitation</keyword>
  <keyword>burns</keyword>
  <keyword>shock</keyword>
  <keyword>fluid creep</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

